# Correction: Ginsenoside compound K attenuates Ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-κB, p38, and JNK MAPK signaling

**Authors:** Shan Lu, Yun Luo, GuiBo Sun, XiaoBo Sun

PMC · DOI: 10.3389/fphar.2025.1499242 · Frontiers in Pharmacology · 2025-06-17

## Full-text entities

- **Genes:** MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}
- **Diseases:** inflammation (MESH:D007249)
- **Chemicals:** Ginsenoside compound K (MESH:C112772)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12210562/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12210562/full.md

---
Source: https://tomesphere.com/paper/PMC12210562